All translations
Enter a message name below to show all available translations.
Found 2 translations.
Name | Current message text |
---|---|
h English (en) | ==Physiological functions== GLP-1 possesses several physiological properties making it (and its [[Functional analog (chemistry)|functional analog]]s) a subject of intensive investigation as a potential treatment of [[diabetes mellitus]], as these actions induce long-term improvements along with the immediate effects. Although reduced GLP-1 secretion has previously been associated with attenuated incretin effect in patients with [[type 2 diabetes]], it is now granted that GLP-1 secretion in patients with type 2 diabetes does not differ from healthy subjects. |
h Japanese (ja) | ==生理学的機能== {{Anchor|Physiological functions}} GLP-1にはいくつかの生理学的特性があるため、GLP-1(およびその[[Functional analog (chemistry)/ja|機能性アナログ]])は[[diabetes mellitus/ja|糖尿病]]の潜在的な治療薬として集中的に研究されている。[[type 2 diabetes/ja|2型糖尿病]]患者におけるGLP-1分泌の低下はインクレチン作用の減弱と以前は関連していたが、現在では2型糖尿病患者におけるGLP-1分泌は健常人と差がないことが認められている。 |